Time course of serum interleukin-6 during COPD exacerbations Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004
Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007
Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017
Il-6 levels in sera and induced sputum of COPD patients during exacerbations and stable period Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Cytokines levels of blood and sputum in COPD exacerbation Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010
Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD Source: Eur Respir J 2007; 30: 472-478 Year: 2007
Characteristic of cytokines levels of blood and sputum in COPD exacerbation Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011
Cytokines profile of blood and sputum in COPD exacerbation Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009
Cytokines profile of blood and sputum in COPD exacerbation Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018
Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD Source: Eur Respir J 2012; 40: 1344-1353 Year: 2012
Concentration of IL-2, IL-4, IL-8 and TNF in blood serum and sputum in bronchial asthma and chronic obstructive pulmonary disease Source: Annual Congress 2009 - Inflammation and airways Year: 2009
Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009
Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017
Sputum VEGF level increases with treatment of COPD acute exacerbation Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012
Cytokine profile of blood and sputum in COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 575s Year: 2006
Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018
The influence of the COPD exacerbation treatment on the MMP-9 concentration in serum, induced sputum and BAL Source: Eur Respir J 2005; 26: Suppl. 49, 298s Year: 2005
Serum C-reactive protein 14 days after a COPD exacerbation and time to the next exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006
Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016
Pulmonary rehabilitation causes a decrease in interleukin-8 and myeloperoxidase levels in sputum of patients with COPD Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009